Status:
COMPLETED
Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™
Lead Sponsor:
NxStage Medical
Conditions:
Kidney Failure, Chronic
End-Stage Renal Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether or not nocturnal hemodialysis is equivalent to short daily hemodialysis on a per treatment basis, using the NxStage System One in the home setting.
Detailed Description
End Stage Renal Disease (ESRD) continues to be a devastating clinical condition. The number of patients in 2004 affected by ESRD in the United States rose to 472,000. More than 104,000 new patients be...
Eligibility Criteria
Inclusion
- Patients must have a stable prescription in the short daily home environment using the NxStage System One prior to enrollment.
Exclusion
- Patients are not eligible if:
- they are currently enrolled in another drug or device study which could impact the successful completion of this study
- they are currently on NHD, or less than 3 months since discontinuing NHD
- if they were previously enrolled in this study.
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT00667511
Start Date
April 1 2008
End Date
May 1 2014
Last Update
January 14 2015
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Satellite Healthcare/Wellbound
San Jose, California, United States, 95128
2
Circle Medical Management
Chicago, Illinois, United States, 60607
3
Indiana University Dialysis Center
Indianapolis, Indiana, United States, 46202
4
Kansas Nephrology Research Institute, LLC
Wichita, Kansas, United States, 67214